In this Healio Video Perspective, Dante J. Pieramici, MD, discusses a trial investigating contrast sensitivity as a visual ...

Kodiak Sciences' pipeline, led by tarcocimab, targets less frequent dosing for retinal diseases but faces tough competition ...

People with type 2 diabetes treated with GLP-1 receptor agonists may face a slightly higher risk for eye complications ...

Recently, second-generation anti-VEGF agents, including brolucizumab, faricimab, and 8 mg aflibercept, have become available ...

The scientific symposium titled "Towards Building a Comprehensive Management Model for Patients with Diabetic Retinopathy and Diabetic Macular Edema at Hospitals" was organized by the Medical Service ...

If you have hypoglycemia during Ozempic treatment, it’s possible that once your blood sugar is stable, the blurred vision will clear. If it doesn’t clear or you have any other vision problems that ...

For adults with diabetes, semaglutide treatment is not associated with increased risk of eye disorders or diabetic retinopathy.

For adults with diabetes, semaglutide treatment is not associated with increased risk of eye disorders or diabetic retinopathy.

KUWAIT: Dasman Diabetes Institute (DDI), established by the Kuwait Foundation for the Advancement of Sciences (KFAS), successfully concluded its Diabetic Retinopathy Workshop, held on August 17 and 18 ...

Ophthalmology Times connects eye care professionals with surgery, imaging, gene therapy, & diagnostic advances to enhance clinical and patient care.

Non-arteritic anterior ischaemic optic neuropathy, or NAION, is a rare but devastating eye condition that occurs when blood ...

Definitive conclusions regarding the association between semaglutide and nonarteritic anterior ischemic optic neuropathy ...